D-0386-2025 Class II Terminated

Recalled by Medisca Inc. — Irving, TX

FDA drug recall D-0386-2025 was initiated by Medisca Inc. on Mar 31, 2025 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Oct 10, 2025). Affected quantity: 161.6 grams.

Recall details

Product Type
Drugs
Report Date
Apr 30, 2025
Initiation Date
Mar 31, 2025
Termination Date
Oct 10, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
161.6 grams

Product description

Bimatoprost powder, Bulk Ingredient, a) 5g (NDC 38779-3066-03), b) 1g (NDC 38779-3066-06), c) 1g (NDC 38779-3066-09) drums, Medisca, Plattsburgh, NY

Reason for recall

CGMP Deviations

Distribution pattern

US Nationwide.

Code information

Lot# 201727/A/B/C/D/E & F, exp. date 05/31/2027, product # 3066 Lot# 208475/A/B/D/E/G/H & I, exp. date 09/30/2028, product # 3066

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0386-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0386-2025. Report a data issue: hello@regdatalab.com.